Access cutting-edge her2+ solid tumors treatment through this clinical trial at a research site in San Diego. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this San Diego location
Access her2+ solid tumors specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related her2+ solid tumors treatment provided free
Check if you qualify for this her2+ solid tumors clinical trial in San Diego, CA
No-Cost Study Care
Local to San Diego
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase II ComboMATCH treatment trial compares the effect of neratinib to the combination of neratinib and palbociclib in treating patients with HER2 positive solid tumors. Neratinib and palbociclib are in a class of medications called kinase inhibitors. They work by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of tumor cells. Giving neratinib and palbociclib in combination may shrink or stabilize cancers that over-expres
Sponsor: National Cancer Institute (NCI)
Yes, this clinical trial (NCT06126276) has an active research site in San Diego, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for her2+ solid tumors treatment options in San Diego, CA, this clinical trial (NCT06126276) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Diego research site is actively enrolling participants for this clinical trial. You'll receive care from experienced her2+ solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all her2+ solid tumors clinical trials near you to find additional studies recruiting in your area.
See all breast cancer clinical trials recruiting in San Diego — not just this study.
Browse Breast Cancer Trials in San Diego →